These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16028772)

  • 21. S100B is not a reliable prognostic index in paediatric TBI.
    Piazza O; Storti MP; Cotena S; Stoppa F; Perrotta D; Esposito G; Pirozzi N; Tufano R
    Pediatr Neurosurg; 2007; 43(4):258-64. PubMed ID: 17627141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of serum S100B levels and intracranial injury in children with closed head trauma.
    Bechtel K; Frasure S; Marshall C; Dziura J; Simpson C
    Pediatrics; 2009 Oct; 124(4):e697-704. PubMed ID: 19786430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of recombinant human erythropoietin on serum S100B protein and interleukin-6 levels after traumatic brain injury in the rat.
    Bian XX; Yuan XS; Qi CP
    Neurol Med Chir (Tokyo); 2010; 50(5):361-6. PubMed ID: 20505289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.
    Beers SR; Berger RP; Adelson PD
    J Neurotrauma; 2007 Jan; 24(1):97-105. PubMed ID: 17263673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary S100B concentrations are increased after brain injury in children: A preliminary study.
    Berger RP; Kochanek PM
    Pediatr Crit Care Med; 2006 Nov; 7(6):557-61. PubMed ID: 17006387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
    Nylén K; Ost M; Csajbok LZ; Nilsson I; Hall C; Blennow K; Nellgård B; Rosengren L
    Acta Neurochir (Wien); 2008 Mar; 150(3):221-7; discussion 227. PubMed ID: 18193148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion.
    Foerch C; du Mesnil de Rochemont R; Singer O; Neumann-Haefelin T; Buchkremer M; Zanella FE; Steinmetz H; Sitzer M
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):322-5. PubMed ID: 12588916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum S100B protein in early management of patients after mild traumatic brain injury.
    Morochovic R; Rácz O; Kitka M; Pingorová S; Cibur P; Tomková D; Lenártová R
    Eur J Neurol; 2009 Oct; 16(10):1112-7. PubMed ID: 19469828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum S100B concentrations are increased after closed head injury in children: a preliminary study.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Kochanek PM
    J Neurotrauma; 2002 Nov; 19(11):1405-9. PubMed ID: 12490005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
    Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
    J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic change of serum protein S100b and its clinical significance in patients with traumatic brain injury.
    Chen DQ; Zhu LL
    Chin J Traumatol; 2005 Aug; 8(4):245-8. PubMed ID: 16042873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of serum S100B protein in critically ill patients without brain injury.
    Routsi C; Stamataki E; Nanas S; Psachoulia C; Stathopoulos A; Koroneos A; Zervou M; Jullien G; Roussos C
    Shock; 2006 Jul; 26(1):20-4. PubMed ID: 16783193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
    Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
    J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum S100B protein is increased in fasting rats.
    Netto CB; Conte S; Leite MC; Pires C; Martins TL; Vidal P; Benfato MS; Giugliani R; Gonçalves CA
    Arch Med Res; 2006 Jul; 37(5):683-6. PubMed ID: 16740441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of S100B to predict severity and cranial CT results in children with TBI.
    Babcock L; Byczkowski T; Mookerjee S; Bazarian JJ
    Brain Inj; 2012; 26(11):1372-80. PubMed ID: 22725661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
    Petzold A; Michel P; Stock M; Schluep M
    J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury.
    Kleindienst A; Ross Bullock M
    J Neurotrauma; 2006 Aug; 23(8):1185-200. PubMed ID: 16928177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients.
    Savola O; Pyhtinen J; Leino TK; Siitonen S; Niemelä O; Hillbom M
    J Trauma; 2004 Jun; 56(6):1229-34; discussion 1234. PubMed ID: 15211130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.